Aberrant TGF‐β signaling and cellular senescence have emerged as central modulators of sustained hepatic inflammation, fibrosis, and cirrhosis, collectively driving the initiation and progression of HCC [9, 10, 11]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.